The first FDA-approved drug for postpartum depression hits the market in June — but it has a $34,000 price tag - CNBCGoogle NewsSat, April 27th - 3:00 AM 2019
Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSO™ (brexanolone) Injection - Business WireGoogle NewsFri, June 14th - 3:00 AM 2019
Is SAGE Therapeutics Inc (SAGE) A Good Stock To Buy? - Yahoo FinanceGoogle NewsWed, June 19th - 3:00 AM 2019
Sage Therapeutics to Host “Sage FutureCast” Webcast - Business WireGoogle NewsThu, June 27th - 3:00 AM 2019
Weather forecast: Slowly but surely we’ll see clearing overnight - RochesterFirstGoogle ScienceFri, June 28th - 9:50 AM 2019
Sage Therapeutics: A Promising CNS Play In July 2019 - Seeking AlphaGoogle NewsMon, July 8th - 3:00 AM 2019
Sage Therapeutics: A Promising CNS Play In July 2019 (NASDAQ:SAGE) - Seeking AlphaGoogle NewsMon, July 8th - 3:00 AM 2019
Is Sage Therapeutics's (NASDAQ:SAGE) 287% Share Price Increase Well Justified? - Yahoo FinanceGoogle NewsTue, July 9th - 3:00 AM 2019
Sage Therapeutics Inc (SAGE) Quote - Morningstar.comGoogle NewsTue, July 16th - 4:34 AM 2019
Sage Therapeutics should price its experimental depression pill on 'value' despite political pressure, CEO says - CNBCGoogle NewsWed, July 24th - 3:00 AM 2019

Pages